Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Localized breast cancer can affect skin and hair.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

A woman's masculine features were caused by a rare ovarian tumor that produced male hormones.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Promising cancer treatments were found, but the manufacturer closed.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

Biological therapy boosts the immune system to effectively fight melanoma.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.